Uterine cancer statistics

Cases

New cases of uterine cancer, 2012, UK

Deaths

Deaths from uterine cancer, 2012, UK

Survival

Survive uterine cancer for 10 or more years, 2010-11, England and Wales

Prevention

Preventable cases of uterine cancer, UK

  • Uterine cancer is the fourth most common cancer in women in the UK, and the most common gynaecological cancer, accounting for 43% of all gynaecological cancers.
  • There were around 8,600 new cases of uterine cancer in the UK in 2012, that’s around 24 women every day
  • Uterine cancer is the 13th most common cancer in the UK (2012).
  • Uterine cancer accounts for 3% of all new cases in the UK (2012).
  • Around a quarter (26%) of cases of uterine cancer are diagnosed in people aged 75 and over.
  • Since the late-1970s, uterine cancer incidence rates have increased by more than three-fifths (62%) in Great Britain.
  • Over the last decade, uterine cancer incidence rates have increased by around a quarter (24%) in the UK.
  • Most uterine cancer cases are diagnosed at an early stage.
  • Most uterine cancers occur in the endometrium.
  • In Europe, around 99,000 new cases of uterine cancer were estimated to have been diagnosed in 2012. The UK incidence rate is 20th highest in Europe.
  • Worldwide, more than 319,000 women were estimated to have been diagnosed with uterine cancer in 2012, with incidence rates varying across the world.
  • 1 in 41 women will be diagnosed with uterine cancer during their lifetime.

Read more in-depth uterine cancer incidence statistics

  • Uterine cancer is the tenth most common cause of cancer death in women in the UK.
  • In 2012, around 2,000 women in the UK died of uterine cancer, that’s more than 5 every day.
  • Around half of deaths from uterine cancer occur in women aged 75 and over.
  • Uterine cancer mortality decreased by a third between the early 1970s and the late 1990s but since then has risen by nearly a quarter.
  • In Europe, around 99,000 new cases of uterine cancer were estimated to have been diagnosed in 2012. The UK incidence rate is 20th highest in Europe.
  • Worldwide, more than 319,000 women were estimated to have been diagnosed with uterine cancer in 2012, with incidence rates varying across the world.

Read more in-depth uterine cancer mortality statistics

  • Almost 7 in 10 (78%) women diagnosed with uterine cancer in England and Wales survive their disease for ten years or more (2010-11).
  • Around 8 in 10 (79%) women diagnosed with uterine cancer in England and Wales survive their disease for five years or more (2010-11).
  • 9 in 10 (90%) women diagnosed with uterine cancer in England and Wales survive their disease for one year or more (2010-11).
  • Uterine cancer survival is highest for women diagnosed aged under 40 years old.
  • Almost 9 in 10 women diagnosed aged 15-39 survive their disease for five years or more, compared with less than 6 in 10 women diagnosed aged 80 and over.
  • Uterine cancer survival is improving and has increased in the last 40 years in the UK.
  • In the 1970s, almost 6 in 10 women diagnosed with uterine cancer survived their disease beyond ten years, now it's almost 8 in 10.
  • When diagnosed at its earliest stage, 95% of women with uterine cancer will survive their disease for five years or more, compared with around 3 in 20 women when diagnosed at the latest stage.

Read more in-depth uterine cancer survival statistics

  • 37% of uterine cancer cases each year in the UK are linked to major lifestyle and other risk factors.
  • A woman’s risk of developing uterine cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
  • Factors which reduce lifetime exposure to oestrogen may relate to lower uterine cancer risk.
  • Overweight and obesity is the main potentially avoidable risk factor for uterine cancer, linked to an estimated 34% of uterine cancer cases in the UK.
  • An estimated 37% of uterine cancer cases in the UK are linked to lifestyle factors including overweight and obesity, lack of physical activity (4%), and hormone replacement therapy (1%).
  • Certain medical conditions and treatments may be linked with higher uterine cancer risk.
  • Some types of oral contraceptives are linked with lower uterine cancer risk.

Read more in-depth uterine cancer risk factors

  • ‘Two-week wait’ referral is the most common route to diagnosis of uterine cancer.
  • ‘Two-week wait’ standards are met by all countries, ‘31-day wait’ is met by all but Northern Ireland and Wales, and ’62-day wait’ is met by all but Wales, Northern Ireland and only partly by Scotland for gynaecological cancers.
  • Around 8 in 10 uterine cancer patients receive major surgical resection as part of their cancer treatment.
  • 9 in 10 patients had a ‘very good’ or ‘excellent’ patient experience.
  • 9 in 10 patients are given the name of their Clinical Nurse Specialist.

Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.

The latest statistics available for uterine cancer in the UK are; incidence 2012, mortality 2012 and survival 2010-2011.

The ICD codes Open a glossary item for uterine cancer are ICD-10 C54-C55, which includes cancers of the corpus uteri (or body of uterus [C54] and cancers of the uterus where the part is unspecified [C55]).

Uterine cancer is sometimes called womb cancer, and is occasionally reported as body of the uterus (C54) alone.

European Age-Standardised Rates were calculated using the 1976 European Standard Population (ESP) unless otherwise stated as calculated with ESP2013. ASRs calculated with ESP2013 are not comparable with ASRs calculated with ESP1976.

Lifetime risk estimates were calculated using incidence, mortality, population and all-cause mortality data for 2012.

Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages, stages Open a glossary item and co-morbidities Open a glossary item. The survival time experienced by an individual patient may be much higher or lower, depending on specific patient and tumour characteristics.

Stage at diagnosis data is not yet routinely available for the UK due to inconsistencies in the collecting and recording of staging data in the past.

Meta-analyses Open a glossary item and systematic reviews Open a glossary item are cited where available, as they provide the best overview of all available research and most take study quality into account. Individual case-control and cohort studies are reported where such aggregated data are lacking.

Most cases of uterine cancer are in the endometrium; accordingly most evidence cited on our risk factors page is for endometrial cancer specifically rather than uterine cancer overall. The specific cancer type is stated where possible.

Routes to diagnosis statistics were calculated from cases of cancer registered in England which were diagnosed in 2006-2010.

Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Uterine cancer is part of the group 'Gynaecological cancer' for cancer waiting times data. Codes vary per country but broadly include: Vulva, vagina, cervix, uterus, ovary, other female genital organs, placenta and secondary cancers of ovary.

Cancer surgical resection rates data is for patients diagnosed in England between 2006 and 2010.

Patient Experience data is for adult patients in England with a primary diagnosis of cancer, who were in active treatment between September and November 2013 and who completed a survey in 2014.

Citation

You are welcome to reuse this Cancer Research UK statistics content for your own work.

Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year]. 

Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK. 

Acknowledgements

We would like to acknowledge the essential work of the cancer registries in the United Kingdom and Ireland Association of Cancer Registries, without which there would be no data.

Rate this page:

No votes yet
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page